Erythema Dyschromicum Perstans.
Lopes Castro AG, Araujo C.
J Cutan Med Surg. 2024 Mar-Apr;28(2):207. doi: 10.1177/12034754241229084. Epub 2024 Jan 25.
A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis.
Kumarasinghe SPW, Pandya A, Chandran V, Rodrigues M, Dlova NC, Kang HY, Ramam M, Dayrit JF, Goh BK, Parsad D.
Int J Dermatol. 2019 Mar;58(3):263-272. doi: 10.1111/ijd.14189. Epub 2018 Sep 3.
Erythema dyschromicum perstans: A case report and systematic review of histologic presentation and treatment.
Leung N, Oliveira M, Selim MA, McKinley-Grant L, Lesesky E.
Int J Womens Dermatol. 2018 Sep 27;4(4):216-222. doi: 10.1016/j.ijwd.2018.08.003. eCollection 2018 Dec.
Erythema dyschromicum perstans.
Novick NL, Phelps R.
Int J Dermatol. 1985 Dec;24(10):630-3. doi: 10.1111/j.1365-4362.1985.tb05712.x.
A Case of Erythema Dyschromicum Perstans.
Ravić Nikolić A, Miličić V, Jovović Dagović B, Mitrović S.
Dermatol Pract Concept. 2022 Apr 1;12(2):e2022106. doi: 10.5826/dpc.1202a106. eCollection 2022 May.
Erythema dyschromicum perstans (ashy dermatosis) unter Dimethylfumarat.
Burlando M, Salvi I, Guadagno A, Cozzani E, Parodi A.
J Dtsch Dermatol Ges. 2022 Nov;20(11):1502-1504. doi: 10.1111/ddg.14889_g.
Erythema Dyschromicum Perstans After Adalimumab Treatment.
Alsisi GG, Alsisi MH, Alhowaish AK, Alshammari WS.
Cureus. 2022 Dec 6;14(12):e32264. doi: 10.7759/cureus.32264. eCollection 2022 Dec.
Erythema dyschromicum perstans.
Knox JM, Dodge BG, Freeman RG.
Arch Dermatol. 1968 Mar;97(3):262-72.
[Erythema dyschromicum perstans].
Sebbag N, Lacour JP.
Ann Dermatol Venereol. 2006 Jan;133(1):79-82. doi: 10.1016/s0151-9638(06)70853-5.
Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders.
Wang RF, Ko D, Friedman BJ, Lim HW, Mohammad TF.
J Am Acad Dermatol. 2023 Feb;88(2):271-288. doi: 10.1016/j.jaad.2022.01.051. Epub 2022 Feb 11.
